Submission Details
| 510(k) Number | K141748 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2014 |
| Decision Date | May 20, 2015 |
| Days to Decision | 324 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K141748 is an FDA 510(k) clearance for the RAPIDFRET ORAL FLUID ASSAY FOR AMPHETAMINE, RAPIDFRET ORAL FLUID AMPHETAMINE CALIBRATOR SET, RAPIDFRET ORAL FLUID AMPHETAMINE CONTROL SET. This device is classified as a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ).
Submitted by Biophor Diagnostics, Inc. (Redwood City, US). The FDA issued a Cleared decision on May 20, 2015, 324 days after receiving the submission on June 30, 2014.
This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K141748 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2014 |
| Decision Date | May 20, 2015 |
| Days to Decision | 324 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |